Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region

Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region

<b>Background:</b> The introduction of biological agents into the clinical armamentarium has modified the management of moderate-severe inflammatory arthritis (IA). However, these drugs can lead to serious adverse events (SAEs) and unpredictable adverse events (AEs) that are difficult to...

Full description

Bibliographic Details
Main Authors: Agnese Gagliardi, Francesco Salvatore Iaquinta, Rosa Daniela Grembiale, Caterina De Sarro, Antonio Fabiano, Domenico Fraija, Caterina Palleria, Rossella Romeo, Adele Emanuela De Francesco, Maria Diana Naturale, Rita Citraro, Luca Gallelli, Antonio Leo, Giovambattista De Sarro
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Pharmaceutics
Subjects:
biological drugs
adverse events (AEs)
pharmacovigilance
Online Access:https://www.mdpi.com/1999-4923/14/11/2328

Internet

https://www.mdpi.com/1999-4923/14/11/2328

Similar Items